...
首页> 外文期刊>Evidence-based nursing >Review: a single dose of oral naproxen or naproxen sodium reduced acute postoperative pain in adults
【24h】

Review: a single dose of oral naproxen or naproxen sodium reduced acute postoperative pain in adults

机译:评论:单次口服萘普生或萘普生钠可减轻成人的急性术后疼痛

获取原文
获取原文并翻译 | 示例

摘要

Pain remains under-treated in postoperative settings despite evidence of the effectiveness of specific treatments. In determining the efficacy, duration of action, and adverse effects of naproxen, a commonly prescribed non-steroidal anti-inflammatory drug (NSAID), the review by Mason ef al presents clinicians with an alternative treatment to opioids for moderate to severe postoperative pain. The review addresses concerns about respiratory depression and impaired gastric motility associated with opioids.2 In considering this alternative, however, clinicians need to balance the benefits of opiate-sparing effects and the possibility of adverse effects.Individuals have varying pain tolerances and may respond dissimilarly to different NSAIDs. The review provides comprehensive information on the effects of a single dose of naproxen or naproxen sodium-information that will be useful to clinicians managing patients who fail to respond to other prescribed NSAIDs or are prescribed lower or higher doses of naproxen or naproxen sodium.Importantly, the meta-analyses showed significant pain relief with single dose usage. As well, the weighted mean time to remedication was 7.5 hours with naproxen sodium, 550 mg, compared with 2.6 hours with placebo. During heavy clinical workloads, less frequent medication requirements could help nurses to improve pain management and benefit patients who often wait for long periods after assessment for administration of pain medication. Although it is not uncommon to use a cut point of 50% pain relief in analyses of treatment effects, nurses should remember the subjective nature of pain and the potential negative effects of lower levels of pain on activities of daily living in some patients with lower pain thresholds. This again underscores the need for individual pain assessment.The systematic review by Mason ef al also highlights the inadequacy of available data on adverse events. Future studies of pain management need to include clear detailed reporting of patient withdrawals by treatment group.
机译:尽管有证据表明特定治疗有效,但术后疼痛仍未得到充分治疗。在确定萘普生(一种常用的非甾体类抗炎药)的疗效,作用时间和不良反应时,Mason等人的综述为临床医生提供了阿片类药物用于中度至重度术后疼痛的替代疗法。该评论解决了与阿片类药物相关的呼吸抑制和胃动力减退的担忧。2然而,在考虑使用这种替代药物时,临床医生需要权衡阿片保留作用的益处和不良反应的可能性。患者的疼痛耐受性各不相同,并且可能会有不同的反应到不同的NSAID。该综述提供了有关单剂量萘普生或萘普生钠信息的影响的全面信息,这些信息对于管理对其他处方NSAID无效或处方了较低或较高剂量的萘普生或萘普生钠的患者的临床医生很有用。荟萃分析显示单次使用可明显缓解疼痛。同样,使用萘普生钠(550毫克)进行补救的加权平均时间为7.5小时,而使用安慰剂则为2.6小时。在繁重的临床工作量中,较少的用药需求可以帮助护士改善疼痛管理,并使在评估用药后通常等待很长时间的患者受益。尽管在分析治疗效果时通常会使用50%的缓解痛点,但护士应记住疼痛的主观性质以及较低水平的疼痛对某些较低疼痛患者的日常生活可能产生的负面影响阈值。这再次强调了个人疼痛评估的必要性。梅森等人的系统评价也突出了不良事件可用数据的不足。疼痛管理的未来研究需要包括按治疗组明确撤出患者的详细报告。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号